B-cell chronic lymphocytic leukemia CD20 positive
Item
cluster of differentiation antigen 20 (cd20)-positive b-cell chronic lymphocytic leukemia [per international workshop on chronic lymphocytic leukemia (iwcll) guidelines]
boolean
C0475774 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
Disease Rai Staging System | Disease Binet Staging System | Treatment required
Item
rai stage iii/iv or binet stage c disease, or rai stage i/ii or binet stage b disease that requires treatment according to iwcll guidelines
boolean
C0012634 (UMLS CUI [1,1])
C1514715 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C1511118 (UMLS CUI [2,2])
C0332121 (UMLS CUI [3])
Chemotherapy Absent Chronic Lymphocytic Leukemia | Therapeutic radiology procedure Absent Chronic Lymphocytic Leukemia | Immunotherapy Absent Chronic Lymphocytic Leukemia | Rituximab Absent | Autoimmune hemolytic anemia | Acute idiopathic thrombocytopenic purpura
Item
no previous treatment for cll chemotherapy, radiotherapy or immunotherapy; no previous rituximab treatment for autoimmune hemolytic anemia (aiha) or idiopathic thrombocytopenic purpura (itp); prior use of steroids for aiha or itp is allowed
boolean
C0392920 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0023434 (UMLS CUI [2,3])
C0021083 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0023434 (UMLS CUI [3,3])
C0393022 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0002880 (UMLS CUI [5])
C0272292 (UMLS CUI [6])
ECOG performance status
Item
eastern cooperative oncology group performance status of 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
Transformation Chronic Lymphocytic Leukemia | Transformation Aggressive cancer B-cell
Item
transformation of cll to aggressive b-cell malignancy
boolean
C0040682 (UMLS CUI [1,1])
C0023434 (UMLS CUI [1,2])
C0040682 (UMLS CUI [2,1])
C2945759 (UMLS CUI [2,2])
C0004561 (UMLS CUI [2,3])
Allergic Reaction Severe Monoclonal Antibody Therapy | Anaphylaxis Severe Monoclonal Antibody Therapy
Item
history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
boolean
C1527304 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0279694 (UMLS CUI [1,3])
C0002792 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0279694 (UMLS CUI [2,3])
Comorbidity Severe Uncontrolled
Item
evidence of severe, uncontrolled concomitant disease
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Communicable Disease | Episode Major Communicable Disease | Requirement Antibiotics Intravenous | Hospitalization Required
Item
known active infection or any major episode of infection requiring treatment with iv antibiotics or hospitalization within 4 weeks before the start of cycle 1
boolean
C0009450 (UMLS CUI [1])
C0332189 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,3])
C1514873 (UMLS CUI [3,1])
C0003232 (UMLS CUI [3,2])
C1522726 (UMLS CUI [3,3])
C1708385 (UMLS CUI [4])
HIV Seropositivity
Item
seropositive for human immunodeficiency virus (hiv)
boolean
C0019699 (UMLS CUI [1])
Chronic Hepatitis B Positive | Serology positive Hepatitis B Surface Antigens
Item
positive for chronic hepatitis b infection (defined as positive hbsag serology)
boolean
C0524909 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0242089 (UMLS CUI [2,1])
C0019168 (UMLS CUI [2,2])
Hepatitis C positive | Hepatitis C Antibodies Serologic tests
Item
positive for hepatitis c (hepatitis c virus [hcv] antibody serology testing)
boolean
C1112419 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C0036743 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Systemic Corticosteroid Therapy | Exception Steroid therapy Low dose
Item
concurrent (or within 7 days prior to fist dose of study treatment) systemic corticosteroid use, except for low-dose corticosteroid therapy used to treat illness other than lymphoma
boolean
C4053960 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0149783 (UMLS CUI [2,2])
C0445550 (UMLS CUI [2,3])